Condition category
Signs and Symptoms
Date applied
03/01/2017
Date assigned
04/01/2017
Last edited
27/04/2018
Prospective/Retrospective
Prospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Chronic knee pain is the name given to long term pain affecting the knee. It can be caused by a range of factors, including osteoarthritis (a condition that occurs when the protective cartilage on the end of bones wears away causing the bones to rub against one another leading to pain, stiffness and a reduction of movement) and patellofemoral pain (also called “runner’s knee”, which involves pain caused by the kneecap resting on the thighbone). Chronic knee pain affects millions of people in the US each year, and is expected to increase in prevalence as the population ages and more people become overweight. This study is looking at a 12-week digital care program for people living with chronic knee pain which has been developed by Hinge Health, Inc. This research is important because people living with long term disorders affecting their musculoskeletal (structural) system rarely receive all of the recommended treatment. The resulting pain, disability, and medical interventions generate avoidable suffering and significant unnecessary spending for healthcare systems. The aim of this study is to find out whether best-practice care for chronic knee pain can be effectively and efficiently delivered digitally and remotely as part of a Digital Care Pathway.

Who can participate?
Adults with chronic knee pain

What does the study involve?
Participants are randomly allocated to one of two groups, with more participants being allocated to the first group. Those in the first group are invited to take part in a 12-week digital care pathway for chronic knee pain designed by Hinge Health. This involves taking part in a 12-week program delivered through a tablet computer with the help of a personal coach and digital sensors. As part of the treatment, participants will perform sensor-guided exercise, read education, perform cognitive behavioral therapy, be more active in their daily lives, and lose weight if necessary. Those in the second group receive three pieces of education on how to take care of their knee and reduce their symptoms. At the start of the study and then again after 11 weeks, participants in both groups have their level of knee pain assessed.

What are the possible benefits and risks of participating?
Participants may benefit from up to a 50% improvement to pain and knee stiffness. There are no known risks involved with participating in this study.

Where is the study run from?
Hinge Health, Inc. (USA)

When is the study starting and how long is it expected to run for?
November 2016 to October 2017

Who is funding the study?
Hinge Health, Inc. (USA)

Who is the main contact?
1. Mr Gabriel Mecklenburg (public)
2. Dr Peter Smittenaar (scientific)

Trial website

Contact information

Type

Public

Primary contact

Mr Gabriel Mecklenburg

ORCID ID

Contact details

Hinge Health
Inc.
818 Mission Street
San Francisco
CA 94107
United States of America

Type

Scientific

Additional contact

Dr Peter Smittenaar

ORCID ID

http://orcid.org/0000-0002-7017-3439

Contact details

7 Greenland Street
London
NW1 0ND
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

A Digital Care Pathway for chronic knee pain: a randomised controlled trial on the efficacy of a 12-week comprehensive digital program to reduce knee pain and improve function

Acronym

Study hypothesis

A 12-week Digital Care Program that includes sensor-guided exercise therapy, education, cognitive behavioral therapy, weight loss (if appropriate), and personal coaching - all delivered remotely - has significant positive effects on knee pain and disability compared to an active control group receiving education only.

Ethics approval

Western Institutional Review Board, 01/06/2016, ref: #20160949

Study design

Multi-centre randomised actively controlled interventional study

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Home

Trial type

Treatment

Patient information sheet

Not available in web format, please use contact details to request a participant information sheet

Condition

Chronic knee pain

Intervention

Participants are randomly assigned to the treatment or control group at a ratio of 3:2. This ratio is enforced by inviting batches of participants as applications for the program are received, and randomly allocating participants in each batch to treatment and control in a 3:2 ratio.

Treatment group: Participants will be invited to participate in a 12-week digital care pathway for chronic knee pain designed by Hinge Health. The “Digital Care Pathway” for chronic knee pain was developed following consensus recommendations by the American College of Rheumatologists, Osteoarthritis Research Society International (OARSI), and the National Institute for Health and Care Excellence (NICE), and reflect up-to-date medical consensus on best-practice care. The treatment group will undergo two weeks of screening and preparation, followed by a comprehensive twelve-week program delivered through a mix of tools, including: an Android-enabled tablet provided to participants with Hinge Health’s mobile application pre-installed, wearable motion sensors designed to work with the mobile application during participants’ exercise therapy, and remote coaching by Hinge Health staff. The treatment intervention combines the main components of best practice care: education, exercise therapy, weight loss guidance where relevant, and addressing of psychosocial factors. The program is designed to achieve high adherence to these components. Using the mobile application, participants will engage with a twelve-week program where their engagement and adherence will be monitored.
First, to drive the adherence to the exercise therapy, a mix of measures will be taken. The biometric sensors offer real-time feedback that allows participants to immediately recognize when they are performing the exercises correctly during self-directed exercise therapy. In addition, each participant is assigned a personal coach from Hinge Health dedicated to supporting and monitoring their engagement with the program and shepherding them through the process. During the first week of the program, a coach will assist participants in tailoring the exercise regime during a remote onboarding session, including exercise selection and training volume, to their condition and goals. Coaches are available remotely on short notice to answer questions, offer feedback or resolve issues with the participant’s mobile applications or biometric sensors.
A second component of the program is educational content delivered to participants through Hinge Health’s mobile application. The content is delivered weekly and designed to coincide with the concurrent phase of the digital care program. Coaches will monitor engagement with the material, engaging participants who have not already done so to consume it and answering questions as they arise.
Third, to address psychosocial factors, each participant will be part of an electronically-mediated social support group comprising fellow employees who are part of the same treatment cohort. This socially oriented feature is delivered entirely through Hinge Health’s mobile application. The social feed will be closely curated by coaches, who will also support the discussion by answering questions and addressing concerns that may arise. In addition to this, participants will engage in bi-weekly cognitive behavioral therapy (CBT) modules designed to help participants confront, address and augment unhelpful thinking and behaviors.
Decades of research, including multiple randomized control trials, demonstrate that CBT can be an effective treatment for individuals with a wide spectrum of chronic pain syndromes. Recent research has established its efficacy through digital and web-based formats as well as treatments delivered by non-psychologists. Where applicable, weight loss is encouraged through a combination of education, coaching, and psychosocial support.

Control group: Participants will be provided with three education articles of similar length to those provided to the treatment group. The education articles are titled “The importance of self-care”, “Surviving setbacks in knee health”, and “Knee pain, communication, and relationships”. The control group is also reminded that their standard care - such as physical therapy and psychological support - remains available to them.

After study completion, participants in the treatment group retain access to the tablet computer and wearable sensors, and can continue to perform their exercises. The control group will be given the opportunity to participate in an upcoming roll-out of the 12-week program, pending their eligibility. Outcomes will be re-assessed at 24, 36, and 64 weeks following completion of the program, but given that many participants in the control group will have crossed over to the treatment arm these long-term outcomes are not part of the primary outcomes of the trial.

Intervention type

Mixed

Phase

Drug names

Primary outcome measures

Knee pain and disability are assessed through the Knee injury and Osteoarthritis Outcome Score (KOOS) pain subscale and KOOS short version, respectively, at baseline and 11 weeks.

Secondary outcome measures

1. Knee pain is assessed using a VAS from 0 to 10 at baseline and 11 weeks
2. Knee stiffness is assessed through a VAS from 0 to 10 at baseline and 11 weeks
3. Surgery interest and intent is assessed through self-reporting using an in-house questionnaire assessing likelihood and attitude at baseline and 11 weeks
4. Ability to self-manage as assessed through the question “Thinking about your symptoms, how well do you feel you understand your condition and your treatment options?” with answer options Not at all, Slightly, Moderately, Very well, Completely, at baseline and 11 weeks

Overall trial start date

01/11/2016

Overall trial end date

01/10/2017

Reason abandoned

Eligibility

Participant inclusion criteria

1. Aged 18-65 years
2. Chronic knee pain for at least 1 month in the past 12 months
3. Provision of informed consent

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

250

Participant exclusion criteria

1. Time in pain in last 12 months is <1 month
2. Rheumatoid arthritis
3. Surgery on the knee less than 3 months ago
4. Injury to the knee less than 3 months ago
5. Age below 18 years
6. Not on employer’s insurance plan
7. Refusal to provide consent

Recruitment start date

16/01/2017

Recruitment end date

01/03/2017

Locations

Countries of recruitment

United States of America

Trial participating centre

Hinge Health, Inc.
818 Mission Street
San Francisco
CA 94107
United States of America

Sponsor information

Organisation

Hinge Health, Inc.

Sponsor details

818 Mission Street
San Francisco
CA 94107
United States of America

Sponsor type

Industry

Website

http://www.hingehealth.com

Funders

Funder type

Industry

Funder name

Hinge Health, Inc.

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Planned submission of a manuscript describing the results of this trial before 2018 in an international peer-reviewed journal that follows ICMJE and CONSORT guidelines for reporting randomized controlled trials.

IPD Sharing plan:
The data are held on secure servers with Hinge Health, Inc. The data are not made available for reasons of participant privacy (given relatively small number of participants).

Intention to publish date

31/12/2018

Participant level data

Not expected to be available

Results - basic reporting

Publication summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29695370

Publication citations

Additional files

Editorial Notes

27/04/2018: Publication reference added.